MiRNA | Number of positive samples (%) | Average counts in subjects | average counts in controls | Stdev of patient | Stdev of control |
---|---|---|---|---|---|
1246 | 62 (100) | 204.8 | 243.2 | 14.6 | 144.2 |
1283 | 62 (100) | 738.0 | 809.8 | 14.1 | 311.3 |
630 | 62 (100) | 2719.4 | 1026.8 | 625.6 | 590.4 |
4516 | 61 (98) | 4537.7 | 8310.6 | 37.8 | 6731.2 |
21-5p | 61 (98) | 946.7 | 1130.3 | 111.7 | 340.2 |
222-3p | 61 (98) | 126.2 | 134.1 | 11.3 | 37.0 |
25-3p | 61 (98) | 223.7 | 202.1 | 13.2 | 92.6 |
601 | 61 (98) | 172.6 | 92.6 | 190.3 | 30.8 |
378e | 60 (97) | 321.0 | 310.7 | 18.5 | 150.5 |
574-5p | 60 (97) | 103.2 | 99.4 | 20.9 | 36.5 |
320e | 60 (97) | 3942.6 | 3182.3 | 84.6 | 2620.1 |
1183 | 59 (95) | 184.7 | 237.6 | 12.5 | 98.4 |
598 | 59 (95) | 204.3 | 249.7 | 18.0 | 109.2 |
363 | 59 (95) | 188.8 | 224.9 | 38.3 | 118.2 |
143-3p | 59 (95) | 184.2 | 179.6 | 11.9 | 75.4 |
302d | 59 (95) | 156.3 | 137.0 | 19.4 | 51.3 |
4443 | 59 (95) | 322.9 | 324.4 | 9.5 | 196.4 |
200a-3p | 58 (94) | 134.5 | 157.9 | 16.3 | 57.7 |
4454 | 58 (94) | 1130.4 | 882.0 | 26.1 | 651.6 |
495 | 57 (92) | 135.0 | 144.4 | 10.2 | 72.6 |
141-3p | 56 (90) | 93.8 | 111.6 | 9.5 | 27.8 |
761 | 56 (90) | 108.5 | 123.1 | 16.3 | 48.3 |
570 | 56 (90) | 119.2 | 91.9 | 46.3 | 34.7 |